To achieve this, MM-bearing recipient mice were transplanted with BM and T cell grafts or with T cell–depleted (TCD) BM and treated with either αTIGIT and lenalidomide or cIg and vehicle (Figure 6B). The gene discussed is FN1; the disease is Miyoshi myopathy.